PRSS12 and sarcopenia: Stabilization of the NMJs could represent a potential therapy for sarcopenia as shown by the injection of a soluble fragment of neuronal agrin (NT- 1654) in neurotrypsin overexpressing mice (Hettwer et al., 2014).